review Open AccessTop 1% cited
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Annals of the Rheumatic Diseases · 2015 · Vol. 74(3) · pp. 480–489
C. Roubille(Hôpital Notre-Dame)Vincent Richer(Hôpital Saint-Luc)Tara Starnino(Université de Montréal)Collette McCourt(University of British Columbia)Alexandra McFarlane(University of Alberta)Patrick Fleming(University of Toronto)Stephanie Siu(Western University)J. Kraft(Lynde Centre for Dermatology)Charles Lynde(Lynde Centre for Dermatology)Janet Pope(St Joseph's Health Care)Wayne Gulliver(Memorial University of Newfoundland)Stephanie Keeling(University of Alberta)Jan Dutz(University of British Columbia)Louis Bessette(Université Laval)Robert Bissonnette(Innovaderm (Canada))Boulos Haraoui✉
Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchCytokine Signaling Pathways and InteractionsMedicinePsoriatic arthritisPsoriasisRheumatoid arthritisMethotrexateDermatologyEtanerceptMeta-analysisArthritisTumor necrosis factor alpha
MeSH terms
Adrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalArthritis, RheumatoidCardiovascular DiseasesHumansMethotrexatePsoriasisRisk FactorsTumor Necrosis Factor-alphaArthritis, PsoriaticAntirheumatic Agents
Funding
- British Association of Dermatologists
Citations
870
FWCI
68.12
field-weighted impact
References
74
Percentile
100%
vs. same field & year
Citations per year
Cited by
Management of psoriasis as a systemic disease: what is the evidence?
British Journal of Dermatology · 2019 · 498 citations
Management of Rheumatoid Arthritis: An Overview
Cells · 2021 · 961 citations
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Atherosclerosis · 2018 · 417 citations
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
Annals of the Rheumatic Diseases · 2016 · 1,297 citations
References
What's the Relative Risk?
JAMA · 1998 · 4,068 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Annals of Internal Medicine · 2009 · 37,606 citations
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Lara D. Veeken · 2009 · 355 citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
New England Journal of Medicine · 2008 · 6,562 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Annals of the Rheumatic Diseases · 2012 · 939 citations
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Annals of the Rheumatic Diseases · 2009 · 1,311 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.